UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Proteolysis of insulin like growth factor-binding protein-3 in the male reproductive tract

The journal of clinical endocrinology and metabolism, 1996-02, Vol.81 (2), p.618-624

1996

Volltextzugriff (PDF)

False Positive Prostate Specific Antigen Values in the Sera of Women with Renal Cell Carcinoma

The Journal of urology, 1992-07, Vol.148 (1), p.21-23

1992

Volltextzugriff (PDF)

Proteolysis of insulin-like growth factor-binding protein-3 in the male reproductive tract

The journal of clinical endocrinology and metabolism, 1996-02, Vol.81 (2), p.618-624

1996

Volltextzugriff (PDF)

False positive prostate specific antigen values in the sera of women with renal cell carcinoma. Editorial comments

The Journal of urology, 1992, Vol.148 (1), p.21-23

1992

Volltextzugriff (PDF)

Dasatinib inhibits the growth of prostate cancer in bone and provides additional protection from osteolysis

British journal of cancer, 2009-07, Vol.101 (2), p.263-268

2009

Volltextzugriff (PDF)

TMPRSS2:ERG Fusion Identifies a Subgroup of Prostate Cancers with a Favorable Prognosis

Clinical cancer research, 2008-06, Vol.14 (11), p.3395-3400

2008

Volltextzugriff (PDF)

Increased Hsp27 after androgen ablation facilitates androgen- independent progression in prostate cancer via signal transducers and activators of transcription 3-mediated suppression of apoptosis

Cancer research (Chicago, Ill.), 2005-12, Vol.65 (23), p.11083-11093

2005

Volltextzugriff (PDF)

Cathepsin K mRNA and Protein Expression in Prostate Cancer Progression

Journal of bone and mineral research, 2003-02, Vol.18 (2), p.222-230

2003

Volltextzugriff (PDF)

SnoRNA U50 is a candidate tumor-suppressor gene at 6q14.3 with a mutation associated with clinically significant prostate cancer

Human molecular genetics, 2008-04, Vol.17 (7), p.1031-1042

2008

Volltextzugriff (PDF)

Plastome data reveal multiple geographic origins of Quercus Group Ilex

PeerJ (San Francisco, CA), 2016-04, Vol.4 (1897), p.e1897-e1897, Article e1897

2016

Volltextzugriff (PDF)

Zoledronic Acid Exhibits Inhibitory Effects on Osteoblastic and Osteolytic Metastases of Prostate Cancer

Clinical cancer research, 2003-01, Vol.9 (1), p.295-306

2003

Volltextzugriff (PDF)

Effects of androgen deprivation therapy and bisphosphonate treatment on bone in patients with metastatic castration‐resistant prostate cancer: Results from the University of Washington Rapid Autopsy Series

Journal of bone and mineral research, 2013-02, Vol.28 (2), p.333-340

2013

Volltextzugriff (PDF)

Administration of zoledronic acid enhances the effects of docetaxel on growth of prostate cancer in the bone environment

BMC cancer, 2006-01, Vol.6 (1), p.15-15, Article 15

2006

Volltextzugriff (PDF)

Inactivation of the Tumor Suppressor PTEN/MMAC1 in Advanced Human Prostate Cancer through Loss of Expression

Proceedings of the National Academy of Sciences - PNAS, 1998-04, Vol.95 (9), p.5246-5250

1998

Volltextzugriff (PDF)

C-Kit and Its Ligand Stem Cell Factor: Potential Contribution to Prostate Cancer Bone Metastasis

Neoplasia (New York, N.Y.), 2008-09, Vol.10 (9), p.996-1003

2008

Volltextzugriff (PDF)

Bone morphogenetic protein signaling in prostate cancer cell lines

Journal of cellular biochemistry, 2004-01, Vol.91 (1), p.151-160

2004

Volltextzugriff (PDF)

Prostate Stem Cell Antigen Is Overexpressed in Prostate Cancer Metastases

Clinical cancer research, 2005-04, Vol.11 (7), p.2591-2596

2005

Volltextzugriff (PDF)

Restoration of tumor suppression in prostate cancer by targeting the E3 ligase E6AP

Oncogene, 2016-12, Vol.35 (48), p.6235-6245

2016

Volltextzugriff (PDF)

Prostate cancer cell phenotypes based on AGR2 and CD10 expression

Modern pathology, 2013-06, Vol.26 (6), p.849-859

2013

Volltextzugriff (PDF)

Osteoprotegerin in prostate cancer bone metastasis

Cancer research (Chicago, Ill.), 2005-03, Vol.65 (5), p.1710-1718

2005

Volltextzugriff (PDF)

Establishment and characterization of osseous prostate cancer models: Intra-tibial injection of human prostate cancer cells

The Prostate, 2002-06, Vol.52 (1), p.20-33

2002

Volltextzugriff (PDF)

Osteoprotegerin and rank ligand expression in prostate cancer

Urology (Ridgewood, N.J.), 2001-04, Vol.57 (4), p.611-616

2001

Volltextzugriff (PDF)

LuCaP 35: A new model of prostate cancer progression to androgen independence

The Prostate, 2003-06, Vol.55 (4), p.239-246

2003

Volltextzugriff (PDF)

Deletion, Mutation, and Loss of Expression of KLF6 in Human Prostate Cancer

The American journal of pathology, 2003-04, Vol.162 (4), p.1349-1354

2003

Volltextzugriff (PDF)

Serum Osteoprotegerin Levels Are Increased in Patients with Advanced Prostate Cancer

Clinical cancer research, 2001-10, Vol.7 (10), p.2977-2983

2001

Volltextzugriff (PDF)

1 – 25 von 124

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(119)
Mit Volltextzugriff
(101)

Publikationsform

Sprache

Englisch
(122)
Französisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Proteolysis of insulin like growth factor-binding protein-3 in the male reproductive tract

False Positive Prostate Specific Antigen Values in the Sera of Women with Renal Cell Carcinoma

Proteolysis of insulin-like growth factor-binding protein-3 in the male reproductive tract

False positive prostate specific antigen values in the sera of women with renal cell carcinoma. Editorial comments

Dasatinib inhibits the growth of prostate cancer in bone and provides additional protection from osteolysis

TMPRSS2:ERG Fusion Identifies a Subgroup of Prostate Cancers with a Favorable Prognosis

Increased Hsp27 after androgen ablation facilitates androgen- independent progression in prostate cancer via signal transducers and activators of transcription 3-mediated suppression of apoptosis

Cathepsin K mRNA and Protein Expression in Prostate Cancer Progression

SnoRNA U50 is a candidate tumor-suppressor gene at 6q14.3 with a mutation associated with clinically significant prostate cancer

Plastome data reveal multiple geographic origins of Quercus Group Ilex

Zoledronic Acid Exhibits Inhibitory Effects on Osteoblastic and Osteolytic Metastases of Prostate Cancer

Effects of androgen deprivation therapy and bisphosphonate treatment on bone in patients with metastatic castration‐resistant prostate cancer: Results from the University of Washington Rapid Autopsy Series

Administration of zoledronic acid enhances the effects of docetaxel on growth of prostate cancer in the bone environment

Inactivation of the Tumor Suppressor PTEN/MMAC1 in Advanced Human Prostate Cancer through Loss of Expression

C-Kit and Its Ligand Stem Cell Factor: Potential Contribution to Prostate Cancer Bone Metastasis

Bone morphogenetic protein signaling in prostate cancer cell lines

Prostate Stem Cell Antigen Is Overexpressed in Prostate Cancer Metastases

Restoration of tumor suppression in prostate cancer by targeting the E3 ligase E6AP

Prostate cancer cell phenotypes based on AGR2 and CD10 expression

Osteoprotegerin in prostate cancer bone metastasis

Establishment and characterization of osseous prostate cancer models: Intra-tibial injection of human prostate cancer cells

Osteoprotegerin and rank ligand expression in prostate cancer

LuCaP 35: A new model of prostate cancer progression to androgen independence

Deletion, Mutation, and Loss of Expression of KLF6 in Human Prostate Cancer

Serum Osteoprotegerin Levels Are Increased in Patients with Advanced Prostate Cancer

Suchergebnisse filtern